Literature DB >> 9795200

Functional identification of the promoter of the gene encoding the Rhesus monkey beta-amyloid precursor protein.

W Song1, D K Lahiri.   

Abstract

Misregulation of the transcription of the beta-amyloid precursor protein (betaAPP) gene is implicated in the pathogenesis of Alzheimer's disease (AD). Here we characterize the 5'-flanking region, the first exon and intron of the betaAPP gene of the Rhesus monkey (rhbetaAPP). For functional analysis, transient transfection in PC12 cells was performed with a series of 5'-deletion constructs (fused with a reporter gene), that extended as far upstream as -7900 down to -1bp. Chloramphenicol acetyltransferase/promoter fusion assays showed that both -7900/+104 and -75/+104-bp regions possessed strong promoter activity. However, -2542/+104bp had the strongest promoter activity, whereas -204/+104bp showed a major reduction in activity and -47/+104bp showed almost a complete loss of activity. A region from -75 to +104bp was essential for minimal basic promoter activity because mutation at the activating site of an upstream stimulator factor (USF) within this region abolished the promoter activity. The very upstream region (-5529/-3416bp) displayed a negative effect on promoter activity. Two blocks of the sequence, 641bp (-1131 /-490) and 105bp (-309/-204), acted as positive regulators for promoter activity. Another 61-bp block (-204/-143) acted as a negative regulator. Gel shift assay indicated that the -249-242-bp region contains a binding domain for the AP-2 transcription factor. No second promoter or bidirectional promoter was observed. A region spanning the first exon and part of the first intron (+99 to +6800bp) acted as a negative regulator. These results suggest that a region of -75 to +104bp, which contains the pyrimidine-rich initiator element, the 5'-untranslated region and the binding site for USF, constitute the minimal promoter element and that interactions between multiple positive and negative elements, the USF and initiator element are crucial for transcription of the TATA-less betaAPP promoter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795200     DOI: 10.1016/s0378-1119(98)00340-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

1.  Efficient DNA transfection in neuronal and astrocytic cell lines.

Authors:  C Ghosh; W Song; D K Lahiri
Journal:  Mol Biol Rep       Date:  2000-06       Impact factor: 2.316

2.  Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease.

Authors:  Jessie Theuns; Nathalie Brouwers; Sebastiaan Engelborghs; Kristel Sleegers; Veerle Bogaerts; Ellen Corsmit; Tim De Pooter; Cornelia M van Duijn; Peter P De Deyn; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2006-04-10       Impact factor: 11.025

3.  Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis.

Authors:  Jason A Bailey; Bryan Maloney; Yuan-Wen Ge; Debomoy K Lahiri
Journal:  Gene       Date:  2011-06-25       Impact factor: 3.688

4.  MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients.

Authors:  Justin M Long; Balmiki Ray; Debomoy K Lahiri
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

Review 5.  Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders.

Authors:  Justin M Long; Debomoy K Lahiri
Journal:  Exp Neurol       Date:  2012-01-05       Impact factor: 5.330

6.  BACE1 gene promoter is differentially regulated: detection of a novel promoter region for its cell type-specific regulation.

Authors:  Debomoy K Lahiri; Bryan Maloney; Yuan-Wen Ge
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 7.  Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.

Authors:  Kumar Sambamurti; Nigel H Greig; Debomoy K Lahiri
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

8.  Co-localization and distribution of cerebral APP and SP1 and its relationship to amyloidogenesis.

Authors:  Brian Brock; Riyaz Basha; Katie DiPalma; Amy Anderson; G Jean Harry; Deborah C Rice; Bryan Maloney; Debomoy K Lahiri; Nasser H Zawia
Journal:  J Alzheimers Dis       Date:  2008-02       Impact factor: 4.472

Review 9.  Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene.

Authors:  Debomoy K Lahiri
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  PuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer's amyloid-β precursor protein via a tissue-specific proximal regulatory element (PRE).

Authors:  Debomoy K Lahiri; Bryan Maloney; Jack T Rogers; Yuan-Wen Ge
Journal:  BMC Genomics       Date:  2013-01-31       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.